Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,367 | -64,259 | -34,507 | -4,143 | -18,582 |
| Depreciation Amortization | 15,481 | 15,312 | 15,087 | 164 | 567 |
| Income taxes - deferred | -5,280 | N/A | N/A | N/A | N/A |
| Accounts receivable | -316 | 511 | 381 | 424 | 106 |
| Other Working Capital | -4,110 | -4,193 | -2,620 | -279 | -8,766 |
| Other Operating Activity | 38,673 | 38,588 | 11,234 | -1,052 | 3,583 |
| Operating Cash Flow | $-18,919 | $-14,041 | $-10,425 | $-4,886 | $-23,092 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 18 |
| PPE Investments | -522 | -123 | -111 | -97 | -565 |
| Purchase Of Investment | -14,935 | N/A | N/A | N/A | -8,761 |
| Sale Of Investment | 2,000 | 2,000 | 2,000 | 2,000 | 7,000 |
| Investing Cash Flow | $-13,457 | $1,877 | $1,889 | $1,903 | $-2,308 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -59 | -44 | -28 | -14 | -54 |
| Common Stock Issued | 27,709 | 7,314 | 5,232 | 5,297 | 36,105 |
| Common Stock Repurchased | -16 | -15 | -15 | -15 | -23 |
| Other Financing Activity | -684 | -684 | -452 | -224 | -171 |
| Financing Cash Flow | $26,950 | $6,571 | $4,737 | $5,044 | $35,857 |
| Exchange Rate Effect | 396 | 216 | 220 | -73 | -95 |
| Beginning Cash Position | 46,354 | 46,354 | 46,354 | 46,354 | 35,992 |
| End Cash Position | 41,324 | 40,977 | 42,775 | 48,342 | 46,354 |
| Net Cash Flow | $-5,030 | $-5,377 | $-3,579 | $1,988 | $10,362 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,919 | -14,041 | -10,425 | -4,886 | -23,092 |
| Capital Expenditure | -522 | -123 | -111 | -97 | -565 |
| Free Cash Flow | -19,441 | -14,164 | -10,536 | -4,983 | -23,657 |